A

Ambulero

3 employees

Ambulero is a cell and gene therapy spin-out of the University of Miami focused on advancing new therapies to fight vascular disease.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Life Science
Therapeutics
Genetics

Date founded

2019

Funding rounds raised

Total raised

$5.5M

from 1 investors over 1 rounds

A

Ambulero raised $5.5M on January 25, 2021

Investors: Orphinic Scientific

FAQ